TY - JOUR AU - Roberts, J. A. AU - Pea, F. AU - Lipman, J. PY - 2013 DA - 2013// TI - The clinical relevance of plasma protein binding changes JO - Clin Pharmacokinet VL - 52 UR - https://doi.org/10.1007/s40262-012-0018-5 DO - 10.1007/s40262-012-0018-5 ID - Roberts2013 ER - TY - JOUR AU - Roberts, J. A. AU - Lipman, J. PY - 2006 DA - 2006// TI - Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis JO - Clin Pharmacokinet VL - 45 UR - https://doi.org/10.2165/00003088-200645080-00001 DO - 10.2165/00003088-200645080-00001 ID - Roberts2006 ER - TY - JOUR AU - Gurevich, K. G. AU - Piataev, N. A. AU - Beliaev, A. N. AU - Romanov, M. D. PY - 2006 DA - 2006// TI - Comparative pharmacokinetics of erythromycin target cell-associated transport and intravenous administration in patients with pneumonia JO - Antibiot Khimioter VL - 51 ID - Gurevich2006 ER - TY - JOUR AU - Ulldemolins, M. AU - Roberts, J. A. AU - Rello, J. AU - Paterson, D. L. AU - Lipman, J. PY - 2011 DA - 2011// TI - The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients JO - Clin Pharmacokinet VL - 50 UR - https://doi.org/10.2165/11539220-000000000-00000 DO - 10.2165/11539220-000000000-00000 ID - Ulldemolins2011 ER - TY - JOUR AU - Hayashi, Y. AU - Lipman, J. AU - Udy, A. A. AU - Ng, M. AU - McWhinney, B. AU - Ungerer, J. AU - Lust, K. AU - Roberts, J. A. PY - 2013 DA - 2013// TI - β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia JO - Int J Antimicrob Agents VL - 41 UR - https://doi.org/10.1016/j.ijantimicag.2012.10.002 DO - 10.1016/j.ijantimicag.2012.10.002 ID - Hayashi2013 ER - TY - JOUR AU - Smith, B. S. AU - Yogaratnam, D. AU - Levasseur-Franklin, K. E. AU - Forni, A. AU - Fong, J. PY - 2012 DA - 2012// TI - Introduction to drug pharmacokinetics in the critically ill patient JO - Chest VL - 141 UR - https://doi.org/10.1378/chest.11-1396 DO - 10.1378/chest.11-1396 ID - Smith2012 ER - TY - JOUR AU - Boffito, M. AU - Back, D. J. AU - Blaschke, T. F. AU - Rowland, M. AU - Bertz, R. J. AU - Gerber, J. G. AU - Miller, V. PY - 2003 DA - 2003// TI - Protein binding in antiretroviral therapies JO - AIDS Res Hum Retroviruses VL - 19 UR - https://doi.org/10.1089/088922203769232629 DO - 10.1089/088922203769232629 ID - Boffito2003 ER - TY - JOUR AU - Belousov, I. B. AU - Gurevich, K. G. PY - 2006 DA - 2006// TI - Clinical pharmacology of antiretroviral agents JO - Antibiot Khimioter VL - 51 ID - Belousov2006 ER - TY - JOUR AU - Gheorghe, L. AU - Iacob, S. AU - Simionov, I. AU - Vadan, R. AU - Constantinescu, I. AU - Caruntu, F. AU - Sporea, I. AU - Grigorescu, M. PY - 2011 DA - 2011// TI - Weight-based dosing regimen of peg-interferon α-2b for chronic hepatitis delta: a multicenter Romanian trial JO - J Gastrointestin Liver Dis VL - 20 ID - Gheorghe2011 ER - TY - JOUR AU - Gane, E. J. AU - Rouzier, R. AU - Stedman, C. AU - Wiercinska-Drapalo, A. AU - Horban, A. AU - Chang, L. AU - Zhang, Y. AU - Sampeur, P. AU - Nájera, I. AU - Smith, P. AU - Shulman, N. S. AU - Tran, J. Q. PY - 2011 DA - 2011// TI - Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients JO - J Hepatol VL - 55 UR - https://doi.org/10.1016/j.jhep.2011.01.046 DO - 10.1016/j.jhep.2011.01.046 ID - Gane2011 ER - TY - JOUR AU - Brodie, M. J. AU - Muir, S. E. AU - Agnew, E. AU - MacPhee, G. J. AU - Volo, G. AU - Teasdale, E. AU - MacPherson, P. PY - 1985 DA - 1985// TI - Protein binding and CSF penetration of phenytoin following acute oral dosing in man JO - Br J Clin Pharmacol VL - 19 UR - https://doi.org/10.1111/j.1365-2125.1985.tb02627.x DO - 10.1111/j.1365-2125.1985.tb02627.x ID - Brodie1985 ER - TY - CHAP AU - Deo, A. K. AU - Theil, F. P. AU - Nicolas, J. M. PY - 2013 DA - 2013// TI - Confounding parameters in preclinical assessment of blood–brain barrier permeation: an overview with emphasis on species differences and effect of disease states BT - Mol Pharm ID - Deo2013 ER - TY - JOUR AU - Fang, W. AU - Lv, P. AU - Geng, X. AU - Shang, E. AU - Yang, Q. AU - Sha, L. AU - LI, Y. PY - 2013 DA - 2013// TI - Penetration of verapamil across blood brain barrier following cerebral ischemia depending on both paracellular pathway and P-glycoprotein transportation JO - Neurochem Int VL - 62 UR - https://doi.org/10.1016/j.neuint.2012.10.012 DO - 10.1016/j.neuint.2012.10.012 ID - Fang2013 ER - TY - JOUR AU - Gao, B. AU - Yeap, S. AU - Clements, A. AU - Balakrishnar, B. AU - Wong, M. AU - Gurney, H. PY - 2012 DA - 2012// TI - Evidence for therapeutic drug monitoring of targeted anticancer therapies JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2012.43.5362 DO - 10.1200/JCO.2012.43.5362 ID - Gao2012 ER - TY - JOUR AU - Sklifas, A. N. AU - Zhalimov, V. K. AU - Temnov, A. A. AU - Kukushkin, N. I. PY - 2012 DA - 2012// TI - Blood plasma protein adsorption capacity of perfluorocarbon emulsion stabilized by proxanol 268 (in vitro and in vivo studies) JO - Biofizika VL - 57 ID - Sklifas2012 ER - TY - CHAP AU - Avery, L. B. AU - Sacktor, N. AU - McArthur, J. C. AU - Hendrix, C. W. PY - 2013 DA - 2013// TI - Protein-free Efavirenz is equivalent in cerebrospinal fluid and blood plasma: Applying the law of mass action to predict protein-free drug concentration BT - Antimicrob Agents Chemother ID - Avery2013 ER - TY - JOUR AU - Kazmi, N. AU - Hossain, M. A. AU - Phillips, R. M. AU - Al-Mamun, M. A. AU - Bass, R. PY - 2012 DA - 2012// TI - Avascular tumour growth dynamics and the constraints of protein binding for drug transportation JO - J Theor Biol VL - 313 UR - https://doi.org/10.1016/j.jtbi.2012.07.026 DO - 10.1016/j.jtbi.2012.07.026 ID - Kazmi2012 ER - TY - JOUR AU - Ghobadi, C. AU - Johnson, T. N. AU - Aarabi, M. AU - Almond, L. M. AU - Allabi, A. C. AU - Rowland-Yeo, K. AU - Jamei, M. AU - Rostami-Hodjegan PY - 2011 DA - 2011// TI - Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance JO - Clin Pharmacokinet VL - 50 UR - https://doi.org/10.2165/11594420-000000000-00000 DO - 10.2165/11594420-000000000-00000 ID - Ghobadi2011 ER - TY - JOUR AU - Brill, M. J. AU - Diepstraten, J. AU - van Rongen, A. AU - van Kralingen, S. AU - van den Anker, J. N. AU - Knibbe, C. A. PY - 2012 DA - 2012// TI - Impact of obesity on drug metabolism and elimination in adults and children JO - Clin Pharmacokinet VL - 51 UR - https://doi.org/10.2165/11599410-000000000-00000 DO - 10.2165/11599410-000000000-00000 ID - Brill2012 ER - TY - JOUR AU - Anderson, G. D. PY - 2005 DA - 2005// TI - Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach JO - Clin Pharmacokinet VL - 44 UR - https://doi.org/10.2165/00003088-200544100-00001 DO - 10.2165/00003088-200544100-00001 ID - Anderson2005 ER - TY - JOUR AU - Hanley, M. J. AU - Abernethy, D. R. AU - Greenblatt, D. J. PY - 2010 DA - 2010// TI - Effect of obesity on the pharmacokinetics of drugs in humans JO - Clin Pharmacokinet VL - 49 UR - https://doi.org/10.2165/11318100-000000000-00000 DO - 10.2165/11318100-000000000-00000 ID - Hanley2010 ER - TY - JOUR AU - Schwartz, J. B. PY - 2003 DA - 2003// TI - The influence of sex on pharmacokinetics JO - Clin Pharmacokinet VL - 42 UR - https://doi.org/10.2165/00003088-200342020-00001 DO - 10.2165/00003088-200342020-00001 ID - Schwartz2003 ER - TY - JOUR AU - Demyanets, S. AU - Wojta, J. PY - 2012 DA - 2012// TI - Sex differences in effects and use of anti-inflammatory drugs JO - Handb Exp Pharmacol VL - 214 UR - https://doi.org/10.1007/978-3-642-30726-3_20 DO - 10.1007/978-3-642-30726-3_20 ID - Demyanets2012 ER - TY - JOUR AU - Barnard, R. AU - Gurevich, K. G. PY - 2005 DA - 2005// TI - In vitro bioassay as a predictor of in vivo response JO - Theor Biol Med Model VL - 2 UR - https://doi.org/10.1186/1742-4682-2-3 DO - 10.1186/1742-4682-2-3 ID - Barnard2005 ER - TY - BOOK AU - Antroshkin, K. A. AU - Gurevich, K. G. AU - Duhanin, A. S. AU - Kareva, E. N. AU - Matushin, A. I. AU - Ogurzov, S. I. AU - Semeikin, A. V. AU - Sergeev, P. V. AU - Shimanoskii, N. L. PY - 2010 DA - 2010// TI - Biochemical Pharmacology PB - Medical Information Agency CY - Moscow ID - Antroshkin2010 ER - TY - JOUR AU - Berezhkovskiy, L. M. PY - 2012 DA - 2012// TI - Determination of hepatic clearance with the account of drug-protein binding kinetics JO - J Pharm Sci VL - 101 UR - https://doi.org/10.1002/jps.23235 DO - 10.1002/jps.23235 ID - Berezhkovskiy2012 ER - TY - BOOK AU - Belousov, Y. B. AU - Gurevich, K. G. PY - 2006 DA - 2006// TI - Particular and common clinical pharmacokinetics PB - Remedium CY - Moscow ID - Belousov2006 ER -